ME
MRNY icon

McIlrath & Eck’s YieldMax MRNA Option Income Strategy ETF MRNY Stock Holding History

McIlrath & Eck’s Portfolio MRNY Stock Details MRNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-453
Closed -$12.5K – 960
2025
Q1 		$12.5K Buy
+453
New +$17.4K ﹤0.01% 572

Other funds holding MRNY

TI
Tidal Investments Milwaukee, Wisconsin $47.4B AUM 59.58% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
WCM
Winebrenner Capital Management Louisville, Kentucky $164M AUM 12.81% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
AWM
AE Wealth Management Topeka, Kansas $18.5B AUM 19.51% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
Belvedere Trading
Belvedere Trading Chicago, Illinois $87.6B AUM 131.08% 1-Year Est. Return
TAM
Tucker Asset Management Littleton, Colorado $343M AUM 17.55% 1-Year Est. Return

McIlrath & Eck's MRNY Position: Q2 2025 in Review

McIlrath & Eck sold out of YieldMax MRNA Option Income Strategy ETF (MRNY) in Q2 2025, closing a stake of 453 shares — an estimated $12.5K sold.

McIlrath & Eck first reported a position in MRNY in Q1 2025 and held it in 1 quarter. The position peaked at $12.5K in Q1 2025. 12 funds tracked by Wall St. Rank hold MRNY as of Q2 2025.

  • McIlrath & Eck reported no remaining YieldMax MRNA Option Income Strategy ETF position as of Q2 2025 after selling out during the quarter.
  • McIlrath & Eck sold 453 YieldMax MRNA Option Income Strategy ETF shares in Q2 2025, an estimated $12.5K.
  • McIlrath & Eck first reported a position in YieldMax MRNA Option Income Strategy ETF in Q1 2025 and held it in 1 quarter.
  • McIlrath & Eck's YieldMax MRNA Option Income Strategy ETF position peaked at $12.5K in Q1 2025.
  • 12 funds tracked by Wall St. Rank held YieldMax MRNA Option Income Strategy ETF as of Q2 2025.

Based on McIlrath & Eck's 13F filing for Q2 2025, filed 14 Aug 2025.